You have 9 free searches left this month | for more free features.

City

Changchun (1)

Guangzhou (1)

Condition

Non-Alcoholic Steatohepatitis (NASH) (1)

Nonalcoholic Steatohepatitis (NASH) (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Guangdong Raynovent Biotech Co., Ltd (2)

Collaborator

Intervention

zsp1601 (2)

placebo (1)

zsp1601 placebo (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

zsp1601

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Nonalcoholic Steatohepatitis (NASH) Trial in Guangzhou (ZSP1601, Placebo)

Not yet recruiting

Nonalcoholic Steatohepatitis (NASH)

ZSP1601
Placebo

Guangzhou, China

NanFang Hospital

Jan 10, 2023

Non-Alcoholic Steatohepatitis (NASH) Trial in Changchun (ZSP1601, ZSP1601 Placebo)

Completed

Non-Alcoholic Steatohepatitis (NASH)

ZSP1601
ZSP1601 Placebo

Changchun, Jilin, China

The First Hospital of Jilin University

Oct 8, 2021